| Bacteria |
0 |
1 |
| Gram-Negative Bacteria |
0 |
0.63 |
| Antibiotics |
0 |
0.6 |
| Hospital-Acquired Infection |
0 |
0.98 |
| Hospital |
0 |
0.4 |
| Urinary Tract Infection |
0 |
0.29 |
| Infective Cystitis |
0 |
0.23 |
| Antibiotic Resistance |
0 |
0.99 |
| Bladder |
0 |
0.16 |
| Pandemic |
0 |
0.16 |
| Washington |
0 |
0.16 |
| Hemodialysis |
0 |
0.1 |
| MRSA |
0 |
0.09 |
| Acinetobacter |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Candida |
0 |
0.08 |
| Dialysis |
0 |
0.08 |
| DNA Sequencing |
0 |
0.08 |
| Drug Resistance |
0 |
0.08 |
| Epidemic |
0 |
0.08 |
| Fever |
0 |
0.08 |
| Health Care Facilities |
0 |
0.08 |
| Health Care Quality |
0 |
0.08 |
| Health Care Quality, Access, and Evaluation |
0 |
0.08 |
| Infection Control |
0 |
0.08 |
| Kidney |
0 |
0.08 |
| Klebsiella Infections |
0 |
0.08 |
| Nursing Homes |
0 |
0.08 |
| Pain |
0 |
0.08 |
| Pseudomonas Aeruginosa Infection |
0 |
0.08 |
| Staphylococcus Aureus Infection |
0 |
0.08 |
| Urgent Care |
0 |
0.08 |
| COVID-19 |
0 |
0.07 |
| Fungal Infection |
0 |
0.07 |
| Genomic Medicine |
0 |
0.07 |
| Pain Management |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Staphylococcal Infection |
0 |
0.07 |